|
The
slide to be stained for MLA
comprised:
1. Skin, 2. Adrenal gland, 3. Desmoplastic malignant melanoma, 4.
Granulosa cell tumour (ovary), 5. Metastatic malignant melanoma.
All tissues were fixed in 10% neutral buffered formalin.
Criteria for assessing a MLA staining as optimal included:
-
A strong, distinct cytoplasmic staining of the normal melanocytes in
the skin.
-
A strong, distinct cytoplasmic staining of the majority of the
neoplastic cells of the metastatic malignant melanoma .
-
A moderate, distinct cytoplasmic staining of scattered cells in the
desmoplastic malignant melanoma.
-
A strong, distinct granular cytoplasmic staining in virtually all
the adrenal cortical cells (clone A103).
-
A moderate to strong, distinct cytoplasmic staining of the luteinized cells in the granulosa cell tumour.
90 laboratories submitted stains. At the assessment 16 achieved
optimal marks (18 %), 27 good (30 %), 28 borderline (31 %) and 19
poor marks (21 %).
The following Abs were used:
mAb clone A103 (Dako, n=66; Novocastra, n=7; Ventana, n=6;
NeoMarkers, n=4; Monosan, n=1)
mAb clones A103 + M2-7C10 + M2-9E3
(Zymed, n=1)
mAb clones M2-7C10 + M2-9E3 (NeoMarkers, n=2; BioCare, n=1)
mAb clones M2-7C10 + M2-9E3 + HMB45 + T311 (BioCare, n=1; Zytomed,
n=1)
Optimal staining for MLA in this assessment was obtained with
the mAb clone A103 (15 out of 84) and mAb cocktail A103+M2-7C10+M2-9E3
(1 out of 1).
Using the mAb clone A103 the protocols giving an optimal result were
all based on heat induced epitope retrieval (HIER) using
Tris-EDTA/EGTA pH 9 or PTM buffer 4 pH 9.0 (Labvision) as buffer. The
mAb was typically diluted in the range of 1:20 – 1:50 depending on
the total sensitivity of the protocol employed. Using these protocol
settings 41 out of 58 (71 %) laboratories produced a sufficient
(optimal or good) staining. All of 7
protocols based on the use of A103 as a Ready-To-Use (RTU) Ab gave
an insufficient staining result (weak/false negative), in spite of protocol settings being otherwise identical to those based on a
concentrated Ab giving sufficient results.
Using the mAb cocktail of the clones A103 + M2-7C10 + M2-9E3 the
protocol giving an optimal result was based on HIER using
Tris-EDTA/EGTA pH 9 as HIER buffer. The Ab was diluted 1:100.
The most frequent causes of insufficient staining were:
- Too low concentration of the primary antibody
- HIER in non-alkaline buffer (typically Citrate pH 6.0)
- Insufficient HIER (too short heating time)
- Less successful primary antibody
- Less successful ready-to-use (RTU) mAb clone A103
Almost all laboratories were able to detect MLA in
the normal melanocytes in the skin and in the metastatic malignant
melanoma, whereas the insufficient staining was characterized by a
too weak or entirely negative reaction of MLA in the
desmoplastic melanoma and melanoma and the granulosa cell tumour
(when using clone A103).
Using clone A103 (single or in a cocktail) the
insufficient staining of the desmoplastic melanoma typically was
accompanied by a too weak or false negative reaction of the granulosa cell tumour in which especially the lutenized cells were
difficult to demonstrate, unless a high sensitive protocol was
applied.
With clone A103 adrenal gland is an appropriate control for MLA. Virtually all the
epithelial cells throughout the adrenal cortex should show a strong
cytoplasmic reaction (while medullar cells are unstained).
Using other clones such as M2-7C10 (which does not react with
steroid producing cells) normal skin should serve as control: The
staining reaction in melanocytes should be as strong as
possible without
any background reaction.
In the assessment of MLA run 16, 79 laboratories participated
out of which 54 (68%) obtained an insufficient mark.
Each was given a specific recommendation to
improve their protocol. 40 of them submitted a new MLA stain in run
20. 22 followed the recommendation, of which 17 improved to
good or optimal (77 %). 18 laboratories did not follow the
recommendation, and 2 of these (11 %) obtained a sufficient staining
in run 20.
Compared to run 16 the proportion of sufficient results has been
increased from 32% to 48%.
Conclusion
The mAb clone A103 used single or in a cocktail with M2-7C10 +
M2-9E3 seems be to the most sensitive marker for MLA. HIER in an
alkaline buffer such as Tris-EDTA/EGTA pH 9 is highly recommended
for optimal performance. Normal adrenal glad is appropriate for
control: The Ab concentration has to be calibrated to give the
strongest possible reaction without cross reaction. Clone A103
as a Ready-To-Use reagent cannot be recommended.
Specific
recommendations given to the participating laboratories seem to have
an impact on the performance. However the number of insufficient
results still is high.
|
|
Fig. 1a.
Optimal staining for Melan A of the skin. The normal melanocytes
show a strong cytoplasmic staining with no reaction of the squamous
epithelial cells. |
Fig. 1b.
Staining for Melan A of the skin using an insufficient protocol
(same field as in Fig. 1a.). The melanocytes are demonstrated.
However, compare with Fig. 2b - 4b, same protocol. Normal
melanocytes can thus not be recommended as control for Melan A.
|
|
Fig. 2a. Optimal
staining for Melan A (clone A103) of the adrenal gland. The majority
of the epithelial cells in zona reticularis show a distinct,
granular cytoplasmic reaction (same protocol used in Fig. 1a - 4a). |
Fig. 2b.
Staining for Melan A (clone A103) of the adrenal gland using an
insufficient protocol (same protocol used in Fig. 1b - 4b. Only
scattered epithelial cells in zona reticularis show a weak reaction
(same field as in Fig. 2a). |
|
Fig. 4a.
Optimal staining for Melan A of the desmoplastic melanoma. Focally
the neoplastic cells show a distinct, cytoplasmic dot-like reaction
(same protocol used in Fig. 1a – 4a). Insert same protocol in the
metastatic melanoma showing an intense reaction |
Fig. 4b.
Insufficient staining for Melan A of the desmoplastic melanoma (same
field as in Fig 4a). All the neoplastic cells are virtually negative
(same protocol used in Fig. 1b – 4b). Insert same protocol in the
metastatic melanoma showing a strong reaction, stressing the
importance to calibrate the protocol on low antigen expressing
tumors/cells. |